Found 830 matching trials
Bintrafusp Alfa With Chemotherapy for Tyrosine Kinase Inhibitor-Resistant EGFR-Mutant Non-small Cell Lung Cancer PHASE2 This phase II trial studies the effect of bintrafusp alfa with pemetrexed a...
Show More Location
M D Anderson Cancer Center
Learn More & Join Trial
Using ctDNA to Determine Therapies for Lung Cancer PHASE2 This is a study to look at whether the presence of circulating tumour DNA (...
Show More Location
Princess Margaret Cancer Centre
Learn More & Join Trial
Study of Osimertinib+Bevacizumab+Chemotherapy for EGFR+ Advanced Non-Small Cell Lung Cancer With Concurrent Mutations PHASE2 This is a single-center, open-label, phase I clinical trial aimed to evalua...
Show More Location
Tianjin Medical University Cancer Institute and Hospital
Learn More & Join Trial
Dose Escalation and Expansion Study of GSK3359609 in Participants With Selected Advanced Solid Tumors (INDUCE-1) PHASE1 GSK3359609 is an anti-Inducible T cell Co-Stimulator (ICOS) receptor agonis...
Show More Location
GSK Investigational Site
Learn More & Join Trial
A Study to Evaluate the Safety of Concurrent Durvalumab With CRT Followed by Durvalumab for Chinese Unresectable Stage III NSCLC PHASE2 This is a prospective, multi-center, single arm study assessing the efficac...
Show More Location
Henan Cancer Hospital
Learn More & Join Trial
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer PHASE3 The purpose of this study is to evaluate the efficacy and safety of divaras...
Show More Location
Alaska Oncology and Hematology
Learn More & Join Trial
Study in Patients With Advanced Non-Small Cell Lung Cancer Treated With Pemetrexed and Carboplatin Plus or Minus Sorafenib PHASE1 The majority of patients with advanced NSCLC treated with standard platinum...
Show More Location
University of Muenster, Dept. of Medicine, Hematology / Oncology
Learn More & Join Trial
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib PHASE1 The purpose of this randomized study is to determine the safety and efficac...
Show More Location
Valkyrie Clinical Trials
Learn More & Join Trial
A Safety and Tolerability Study of NC318 in Combination With Chemotherapy for Subjects With Advanced or Metastatic NSCLC PHASE1 This research study is studying an investigational drug, NC318, as a possib...
Show More Location
Multiple Locations
Learn More & Join Trial
Ensartinib, Carboplatin, Pemetrexed and Bevacizumab for the Treatment of Stage IIIC or IV or Recurrent ALK-Positive Non-small Cell Lung Cancer PHASE1 This phase Ib trial finds the best dose and side effects of ensartinib and ...
Show More Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Learn More & Join Trial